The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II

Author：                  

Publisher： Spandidos Publications

E-ISSN： 1791-244X|35|5|1159-1168

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.35, Iss.5, 2015-01, pp. : 1159-1168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Adenosine A1 Agonist 2-Chloro-N6 Cyclopentyladenosine Inhibits the Angiotensin II-Induced Cardiomyocyte Hypertrophy through the Calcineurin Pathway

By  

Cardiology, Vol. 129, Iss. 3, 2014-10 ,pp. : 153-162

Karger

Access to resources Recommend Favorite

Angiotensin II Antagonism and the Heart: Valsartan in Left Ventricular Hypertrophy

By  

Cardiology, Vol. 91, Iss. 1, 1999-08 ,pp. : 3-7

Karger

Access to resources Recommend Favorite

The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb–mTORC1 signalling and leads to chronic heart failure

By  

THE JOURNAL OF PATHOLOGY, Vol. 235, Iss. 5, 2015-04 ,pp. : 672-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Asymmetric Dimethylarginine in Inflammatory Reactions by Angiotensin II

By  

Journal of Vascular Research, Vol. 44, Iss. 5, 2007-05 ,pp. : 391-402

Karger

Access to resources Recommend Favorite